Literature DB >> 23544716

Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.

Mark J Tullman1.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system that affects approximately 400,000 people in the United States. The etiology of MS is unknown, but it is likely the result of a complex interaction between genetic and environmental factors and the immune system. The clinical manifestations of MS are highly variable, but most patients initially experience a relapsing-remitting course. Patients accumulate disability as a result of incomplete recovery from acute exacerbations and/or gradual disease progression. This article briefly reviews the immunopathology of MS, the symptoms and natural course of the disease, and the recently revised MS diagnostic criteria.

Entities:  

Mesh:

Year:  2013        PMID: 23544716

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  77 in total

Review 1.  Multiple Sclerosis in Latin Americans: Genetic Aspects.

Authors:  Victor M Rivera
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

Review 2.  Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.

Authors:  Andrew J Solomon; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

3.  Application of Item Response Theory to Modeling of Expanded Disability Status Scale in Multiple Sclerosis.

Authors:  A M Novakovic; E H J Krekels; A Munafo; S Ueckert; M O Karlsson
Journal:  AAPS J       Date:  2016-09-15       Impact factor: 4.009

4.  Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans.

Authors:  Richard E Nelson; Yan Xie; Scott L DuVall; Jorie Butler; Aaron W C Kamauu; Kristin Knippenberg; Markus Schuerch; Nadia Foskett; Joanne LaFleur
Journal:  Int J MS Care       Date:  2015 Sep-Oct

Review 5.  The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.

Authors:  Yang Mao-Draayer; Jeffrey Sarazin; David Fox; Elena Schiopu
Journal:  Clin Immunol       Date:  2016-11-23       Impact factor: 3.969

6.  Deep Learning for Predicting Enhancing Lesions in Multiple Sclerosis from Noncontrast MRI.

Authors:  Ponnada A Narayana; Ivan Coronado; Sheeba J Sujit; Jerry S Wolinsky; Fred D Lublin; Refaat E Gabr
Journal:  Radiology       Date:  2019-12-17       Impact factor: 11.105

7.  Deep learning segmentation of gadolinium-enhancing lesions in multiple sclerosis.

Authors:  Ivan Coronado; Refaat E Gabr; Ponnada A Narayana
Journal:  Mult Scler       Date:  2020-05-22       Impact factor: 6.312

Review 8.  Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.

Authors:  Daniel M Hartung
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 9.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

10.  Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.

Authors:  Ike de la Pena; Mibel Pabon; Sandra Acosta; Paul R Sanberg; Naoki Tajiri; Yuji Kaneko; Cesar V Borlongan
Journal:  Cell Med       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.